Evidence map›Paper›PMID 40355897›Full record

ArticleHarm reduction journal2025

Establishing a community advisory board to align harm reduction research with the unique needs of Black and Latine communities.

Simon Kapler, Hira Hassan, Alexander Jeremiah, Katurah Bryant, Presto Crespo, Nesta Felix, Sónyi Elena Lopez, Antonio Morales, Sean Reeves, Ayana Jordan

Abstract read
In one paragraph

Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Simon KaplerNYU Grossman School of Medicine, New York City, USA. simon.kapler@nyulangone.org.ORCID http://orcid.org/0009-0004-8475-0681
Hira HassanNYU Grossman School of Medicine, New York City, USA.
Alexander JeremiahNYU Grossman School of Medicine, New York City, USA.
Katurah BryantNYU Grossman School of Medicine, New York City, USA.
Presto CrespoNYU Grossman School of Medicine, New York City, USA.
Nesta FelixNYU Grossman School of Medicine, New York City, USA.
Sónyi Elena LopezNYU Grossman School of Medicine, New York City, USA.
Antonio MoralesNYU Grossman School of Medicine, New York City, USA.
Sean ReevesNYU Grossman School of Medicine, New York City, USA.
Ayana JordanNYU Grossman School of Medicine, New York City, USA.

Funding

Integrated Safety Optimization Services for People Who Use Drugs In Targeted Areas Of High Overdose RatesR01DA057651 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Ayana Jordan · 2022 to 2026
$3.4M
NIDA NIH HHS 1R01DA057651-01NIDA NIH HHS R01 DA057651
6 · The paper itself

Abstract

Death from opioid use is a growing public health concern, with stark racial and ethnic disparities. The randomized controlled trial described here aims to improve initiation and engagement in harm reduction services for Black and Latine people who use drugs to minimize mortality in these populations. The trial is informed by a Community Advisory Board (CAB) of stakeholders from racial and ethnic minoritized backgrounds committed to promoting health equity in populations disproportionately impacted by the drug overdose crisis. CABs are an underutilized mechanism for engaging communities in research to improve health outcomes. Hence, in this manuscript we outline the process and methods employed in creating a CAB, describe its impact on our research study, and recognize the challenges and adaptations made to the CAB during the study.CAB recruitment targeted active community members from Black and Latine communities in the Bronx, NY and New Haven, CT. After attending community organizational meetings in each place, follow-up email efforts were unsuccessful, prompting a revised approach. Emphasizing the study's focus on historically excluded voices, "research-naïve" individuals were sought through online searches and local grassroots organizations, excluding those affiliated with harm reduction groups to minimize bias. Once CAB members were identified, a remote orientation was held, and the CAB began providing regular feedback on research activities, from participant recruitment to educational script details. CAB members' diverse identities and life experiences generated nuanced discussions, which were distilled into feedback improving research materials and recruitment strategies. In the future, the CAB will also guide data analysis and research publications. Other areas of emphasis have included straightforward language in study materials, balanced messaging about harm reduction recommendations, and specific community outreach opportunities. Practical barriers that needed to be addressed for optimal CAB functioning included timely compensation with minimal institutional burden and assistance with meeting coordination and communication.The CAB has ensured that Black and Latine community voices are included in guiding our study, promoting equitable and ethical research. As harm reduction research advances, it is essential to center this work around the intersectional identities of people who use drugs to prevent the disproportionate burden and deaths among Black and Latine people.

Indexed as

Advisory CommitteesBlack or African AmericanHarm ReductionHispanic or LatinoOpioid-Related DisordersCommunity-Based Participatory ResearchFemaleHumansMaleBlackCommunity Advisory BoardCommunity-Based Participatory ResearchEquityHarm reductionLatino/x/eOpioids

Identifiers

PMID40355897
PMCPMC12067662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.